The ability of MRP1 to export chemotherapeutic drugs significantly impacts the efficacy of cancer treatment. High levels of MRP1 expression are often correlated with poor clinical outcomes and treatment resistance. Targeting MRP1 to inhibit its function can potentially enhance the sensitivity of cancer cells to chemotherapy, making it a promising therapeutic approach.
